Added to YB: 2024-09-10
Pitch date: 2024-06-30
ONT.L [bullish]
Oxford Nanopore Technologies plc
+28.46%
current return
Author Info
No bio for this author
Company Info
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.
Market Cap
GBP 1.3B
Pitch Price
GBP 0.97
Price Target
N/A
Dividend
N/A
EV/EBITDA
-7.53
P/E
-7.60
EV/Sales
6.70
Sector
Life Sciences Tools and Services
Category
turnaround
Platinum International Health Sciences Fund Added On Portfolio Holding: Oxford Nanopore Technologies plc
ONT.L added to position: Life science tool sector volatile, lower capex spending, cautious procurement, China uncertainty. Oxford Nanopore down 20% Q/Q. Attractive due to price point & diagnostic testing potential. Added to position despite difficult environment.
Read full article (1 min)